133:@0.890196:0.957873:0.914705:0.957873:0.914705:0.938882:0.890196:0.938882:0.007325:0.008593:0.008591
5:@0.941813:0.435294:0.963291:0.435294:0.963291:0.387816:0.941813:0.387816:0.021478
OPTIMIZING NANOPORE SEQUENCING-BASED DETECTION OF STRUCTURAL VARIANTS ENABLES:@0.340931:0.057372:0.882352:0.057372:0.882352:0.040253:0.340931:0.040253:0.008442:0.007975:0.006387:0.003511:0.011112:0.003511:0.006630:0.003511:0.008759:0.008404:0.002988:0.008759:0.007919:0.008759:0.008442:0.008050:0.008442:0.008423:0.006985:0.002988:0.007807:0.006985:0.008442:0.008367:0.006985:0.008759:0.008255:0.003511:0.008759:0.008404:0.005155:0.008121:0.007713:0.007807:0.006985:0.008423:0.002988:0.008423:0.006985:0.006387:0.006985:0.008178:0.006387:0.003511:0.008442:0.008759:0.002988:0.008442:0.006593:0.002988:0.007732:0.006387:0.008367:0.008367:0.008180:0.006387:0.008367:0.008423:0.007919:0.006292:0.002801:0.006966:0.007919:0.008423:0.003511:0.007919:0.008759:0.006313:0.007807:0.002988:0.006985:0.008759:0.007919:0.008236:0.006481:0.006871:0.007807
INDIVIDUALIZED CIRCULATING TUMOR DNA-BASED DISEASE MONITORING IN CANCER PATIENTS:@0.337347:0.073247:0.882352:0.073247:0.882352:0.056128:0.337347:0.056128:0.003511:0.008759:0.008423:0.003511:0.007620:0.003511:0.008423:0.008253:0.007919:0.006481:0.003511:0.006630:0.006985:0.008423:0.002988:0.008255:0.003511:0.008309:0.008255:0.008367:0.006481:0.007097:0.006387:0.003511:0.008759:0.008404:0.002988:0.006387:0.008367:0.011112:0.008442:0.008423:0.002988:0.008423:0.008759:0.007543:0.005155:0.008124:0.007713:0.007807:0.006985:0.008423:0.002988:0.008423:0.003511:0.007807:0.006985:0.007713:0.007807:0.006985:0.002988:0.011112:0.008442:0.008759:0.003511:0.006311:0.008442:0.008423:0.003511:0.008759:0.008404:0.002988:0.003511:0.008759:0.002988:0.008178:0.007919:0.008759:0.008255:0.006985:0.008423:0.002988:0.007581:0.007099:0.006387:0.003511:0.006985:0.008759:0.006311:0.007807
cfDNA isolation: cfDNA was isolated from ascites fluid of Ova2 by using the QIAamp :@0.147059:0.121273:0.886397:0.121273:0.886397:0.100900:0.147059:0.100900:0.008994:0.006209:0.015773:0.015408:0.014929:0.005387:0.005615:0.007875:0.010934:0.005433:0.008811:0.006437:0.005547:0.010843:0.011756:0.004501:0.005387:0.008994:0.006209:0.015773:0.015408:0.014929:0.005387:0.014723:0.009291:0.007670:0.005387:0.005615:0.007875:0.010934:0.005433:0.008811:0.006209:0.009106:0.011391:0.005387:0.006414:0.007442:0.010843:0.017645:0.005387:0.009291:0.007875:0.008994:0.005273:0.006209:0.009039:0.007670:0.005387:0.005638:0.005296:0.011413:0.005547:0.011391:0.005387:0.010843:0.006209:0.005387:0.016892:0.009838:0.009291:0.010432:0.005387:0.010843:0.009724:0.005387:0.011413:0.007601:0.005615:0.011459:0.009861:0.005387:0.006620:0.011299:0.009039:0.005387:0.015979:0.006483:0.014700:0.009085:0.017280:0.011276:0.004109
Circulating Nucleic Acid Kit (Qiagen) according to the manufacturer’s protocol. Plasma :@0.147059:0.141852:0.886482:0.141852:0.886482:0.121479:0.147059:0.121479:0.014609:0.005615:0.007442:0.009108:0.011550:0.005433:0.008811:0.006437:0.005615:0.011459:0.009861:0.004314:0.015408:0.011345:0.008765:0.005182:0.009039:0.005547:0.008994:0.004314:0.014335:0.008994:0.005547:0.011391:0.004314:0.014472:0.005271:0.006437:0.004314:0.006939:0.016228:0.005798:0.009199:0.009656:0.009039:0.011756:0.006939:0.004314:0.009291:0.008994:0.008994:0.010843:0.007442:0.011391:0.005615:0.011459:0.009861:0.004314:0.006209:0.011048:0.004314:0.006620:0.011299:0.009039:0.004314:0.017577:0.009085:0.011391:0.011413:0.006209:0.009291:0.009108:0.006163:0.011413:0.007442:0.009039:0.007076:0.001735:0.007670:0.004314:0.011071:0.007442:0.010820:0.006209:0.011276:0.008994:0.010934:0.004976:0.004497:0.004314:0.011824:0.005430:0.009291:0.007604:0.017577:0.009291:0.004109
samples from patients with prostate cancer were obtained longitudinally during treat-:@0.147059:0.162431:0.882353:0.162431:0.882353:0.142058:0.147059:0.142058:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.006072:0.006414:0.007442:0.010843:0.017645:0.006072:0.011368:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.007670:0.006072:0.014723:0.005273:0.006617:0.011459:0.006072:0.011071:0.007442:0.010957:0.007510:0.006551:0.008811:0.006209:0.009039:0.006072:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.006072:0.014518:0.009039:0.007442:0.009039:0.006072:0.010957:0.010797:0.006551:0.009085:0.005615:0.011596:0.009108:0.011391:0.006072:0.005182:0.010840:0.011461:0.009861:0.005271:0.006166:0.011345:0.011391:0.005615:0.011687:0.009405:0.005387:0.005182:0.009724:0.006072:0.011048:0.011413:0.007807:0.005615:0.011459:0.009861:0.006072:0.006437:0.007442:0.009291:0.008811:0.006506:0.007533
ment in 3x10 ml CellSave preservative tubes (Menarini Silicon Biosystems, Huntingdon :@0.147059:0.183009:0.886462:0.183009:0.886462:0.162636:0.147059:0.162636:0.017485:0.009039:0.011391:0.006437:0.003983:0.005615:0.011756:0.003983:0.010432:0.010089:0.010432:0.010432:0.003983:0.017759:0.005250:0.003983:0.014997:0.008948:0.005387:0.005250:0.010112:0.008925:0.009633:0.009039:0.003983:0.011071:0.007442:0.009039:0.007873:0.009039:0.008400:0.009838:0.008811:0.006437:0.005547:0.009633:0.009039:0.003983:0.006166:0.011345:0.011251:0.009039:0.007670:0.003983:0.006939:0.018969:0.009039:0.011687:0.009087:0.007807:0.005615:0.011756:0.005615:0.003981:0.010112:0.005752:0.005250:0.005547:0.008994:0.010843:0.011756:0.003983:0.012486:0.005547:0.010957:0.007761:0.009724:0.007510:0.006209:0.009039:0.017508:0.007670:0.004497:0.003983:0.015842:0.011413:0.011391:0.006437:0.005615:0.011459:0.009656:0.011322:0.010843:0.011756:0.004109
Valley, PA, USA) and processed within 96 hours as previously described . Circulating :@0.147059:0.203588:0.886461:0.203588:0.886461:0.183215:0.147059:0.183215:0.012874:0.009405:0.005387:0.005182:0.009336:0.007989:0.004497:0.005100:0.010249:0.014929:0.004497:0.005100:0.016024:0.010112:0.014929:0.006939:0.005100:0.009087:0.011596:0.011391:0.005100:0.011071:0.007442:0.011276:0.008994:0.009039:0.007533:0.007875:0.009108:0.011391:0.005100:0.014723:0.005273:0.006620:0.011459:0.005615:0.011756:0.005100:0.010432:0.010432:0.005100:0.011299:0.010820:0.011413:0.007624:0.007670:0.005100:0.009291:0.007670:0.005102:0.011071:0.007442:0.009336:0.009838:0.005547:0.010820:0.011413:0.007556:0.005182:0.009724:0.005100:0.011322:0.009039:0.007875:0.008994:0.007807:0.005547:0.011254:0.009108:0.011391:0.018245:0.004497:0.005100:0.014609:0.005615:0.007442:0.009108:0.011550:0.005433:0.008811:0.006437:0.005615:0.011459:0.009861:0.004109
373:@0.758570:0.195972:0.776816:0.195972:0.776816:0.184095:0.758570:0.184095:0.006082:0.006082:0.006082
DNA was isolated with the QIAsymphony® DSP Circulating DNA Kit (Qiagen) according :@0.147059:0.224167:0.886511:0.224167:0.886511:0.203794:0.147059:0.203794:0.015773:0.015408:0.014929:0.002739:0.014723:0.009291:0.007670:0.002739:0.005615:0.007873:0.010934:0.005433:0.008811:0.006211:0.009106:0.011391:0.002739:0.014723:0.005271:0.006620:0.011459:0.002739:0.006620:0.011299:0.009039:0.002739:0.015979:0.006483:0.014586:0.007761:0.009724:0.017280:0.011162:0.011299:0.010843:0.011368:0.009686:0.005090:0.002739:0.016139:0.009770:0.012167:0.002739:0.014609:0.005615:0.007442:0.009106:0.011550:0.005433:0.008811:0.006437:0.005615:0.011459:0.009861:0.002739:0.015773:0.015408:0.014929:0.002739:0.014472:0.005273:0.006437:0.002739:0.006939:0.016230:0.005798:0.009199:0.009656:0.009039:0.011756:0.006939:0.002739:0.009291:0.008994:0.008994:0.010843:0.007442:0.011391:0.005615:0.011459:0.009861:0.004109
to manufacturer’s protocol with some minor modifications . All cfDNA samples were :@0.147059:0.244745:0.886499:0.244745:0.886499:0.224373:0.147059:0.224373:0.006209:0.011048:0.005045:0.017577:0.009085:0.011391:0.011413:0.006209:0.009291:0.009108:0.006163:0.011413:0.007442:0.009039:0.007076:0.001735:0.007670:0.005033:0.011071:0.007442:0.010820:0.006211:0.011274:0.008994:0.010934:0.005250:0.005045:0.014723:0.005273:0.006620:0.011459:0.005045:0.007873:0.010843:0.017488:0.009039:0.005033:0.017645:0.005615:0.011596:0.010843:0.007807:0.005045:0.017485:0.011276:0.011391:0.005615:0.005684:0.005615:0.009108:0.008811:0.006437:0.005545:0.010845:0.011619:0.007670:0.018207:0.004497:0.005045:0.015066:0.005385:0.005250:0.005045:0.008994:0.006209:0.015773:0.015408:0.014929:0.005045:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.005045:0.014518:0.009039:0.007442:0.009039:0.004109
374:@0.645056:0.237129:0.663301:0.237129:0.663301:0.225252:0.645056:0.225252:0.006082:0.006082:0.006082
quantified by Qubit  fluorometric quantitation (Invitrogen).:@0.147059:0.265324:0.662552:0.265324:0.662552:0.244951:0.147059:0.244951:0.010706:0.011596:0.009085:0.011391:0.006437:0.005615:0.005684:0.005615:0.009108:0.011391:0.004109:0.010843:0.009724:0.004109:0.016433:0.011345:0.010820:0.005273:0.006437:0.019084:0.004109:0.005638:0.005296:0.011345:0.010843:0.007442:0.010843:0.017485:0.009131:0.006437:0.007807:0.005547:0.008994:0.004109:0.010706:0.011596:0.009085:0.011391:0.006437:0.005273:0.006551:0.008811:0.006437:0.005547:0.010843:0.011756:0.004109:0.006939:0.006894:0.011368:0.009838:0.005271:0.006437:0.007442:0.011048:0.009656:0.009039:0.011756:0.006939:0.004497
TM:@0.312779:0.257708:0.331863:0.257708:0.331863:0.245831:0.312779:0.245831:0.007652:0.011432
Quantitative PCR: As primer specificity is essential for reliable interpretation of an end-:@0.147059:0.306482:0.882266:0.306482:0.882266:0.286109:0.147059:0.286109:0.016435:0.011596:0.009085:0.011391:0.006437:0.005273:0.006551:0.008811:0.006437:0.005547:0.009633:0.009039:0.004337:0.012167:0.014678:0.013376:0.004504:0.004337:0.014584:0.007670:0.004337:0.011071:0.007807:0.005615:0.017485:0.009039:0.007807:0.004337:0.007510:0.011505:0.009108:0.008994:0.005615:0.005684:0.005615:0.008994:0.005273:0.006437:0.009724:0.004337:0.005615:0.007670:0.004337:0.009039:0.007533:0.007873:0.009039:0.011393:0.006437:0.005796:0.009405:0.005250:0.004337:0.006024:0.010845:0.007807:0.004337:0.007442:0.008948:0.005250:0.005798:0.009108:0.010911:0.005182:0.009039:0.004337:0.005615:0.011391:0.006209:0.009039:0.007967:0.011071:0.007442:0.009131:0.006551:0.008811:0.006437:0.005547:0.010843:0.011756:0.004337:0.010843:0.006209:0.004337:0.009085:0.011756:0.004337:0.009039:0.011596:0.011391:0.007533
point assay like dPCR, primers for the detection of structural variants were validated :@0.147059:0.327060:0.886416:0.327060:0.886416:0.306687:0.147059:0.306687:0.011505:0.010843:0.005615:0.011391:0.006437:0.006506:0.009291:0.007533:0.007944:0.008925:0.009724:0.006506:0.005250:0.005752:0.010272:0.009039:0.006506:0.011391:0.012167:0.014678:0.013696:0.004497:0.006506:0.011071:0.007807:0.005615:0.017485:0.009039:0.007624:0.007670:0.006506:0.006026:0.010843:0.007807:0.006506:0.006620:0.011299:0.009039:0.006506:0.011322:0.009131:0.006211:0.009106:0.009108:0.006437:0.005547:0.010843:0.011756:0.006506:0.010843:0.006209:0.006506:0.007510:0.006437:0.007967:0.011345:0.009108:0.006163:0.011413:0.007898:0.009405:0.005250:0.006506:0.009838:0.009085:0.007807:0.005798:0.009085:0.011391:0.006437:0.007670:0.006506:0.014518:0.009039:0.007442:0.009039:0.006506:0.009838:0.009405:0.005250:0.005547:0.011571:0.008811:0.006211:0.009106:0.011391:0.004109
by quantitative PCR (qPCR) on whole genome amplified (WGA) tumor and germline :@0.147059:0.347639:0.886494:0.347639:0.886494:0.327266:0.147059:0.327266:0.010843:0.009724:0.005547:0.010706:0.011596:0.009085:0.011391:0.006437:0.005273:0.006551:0.008811:0.006437:0.005547:0.009633:0.009039:0.005547:0.012167:0.014678:0.013376:0.005547:0.006939:0.011025:0.012167:0.014678:0.013376:0.006939:0.005547:0.010843:0.011756:0.005547:0.014792:0.011299:0.010934:0.005182:0.009039:0.005547:0.009656:0.009039:0.011598:0.010843:0.017485:0.009039:0.005547:0.009085:0.017280:0.011162:0.005250:0.005615:0.005684:0.005615:0.009108:0.011391:0.005547:0.006827:0.020268:0.015682:0.014929:0.006939:0.005547:0.006163:0.011413:0.017488:0.010843:0.007807:0.005547:0.009085:0.011596:0.011391:0.005547:0.009656:0.009039:0.007807:0.017759:0.005250:0.005615:0.011598:0.009039:0.004109
DNA. In brief, qPCR was performed by using the CFX96 Touch™ Real-Time PCR De-:@0.147059:0.368218:0.882353:0.368218:0.882353:0.347845:0.147059:0.347845:0.015773:0.015408:0.014929:0.004497:0.005410:0.006894:0.011756:0.005410:0.010820:0.007807:0.005547:0.009039:0.005935:0.004497:0.005410:0.011025:0.012167:0.014678:0.013376:0.005410:0.014723:0.009291:0.007670:0.005410:0.011505:0.009039:0.007807:0.006026:0.010843:0.007807:0.017485:0.009108:0.011391:0.005410:0.010843:0.009724:0.005410:0.011413:0.007601:0.005615:0.011459:0.009861:0.005410:0.006620:0.011299:0.009039:0.005410:0.014678:0.011276:0.014107:0.010432:0.010432:0.005410:0.010866:0.010820:0.011345:0.008765:0.011459:0.007487:0.005410:0.013696:0.009291:0.009405:0.005250:0.007533:0.012737:0.005615:0.017485:0.009039:0.005410:0.012167:0.014678:0.013376:0.005410:0.016230:0.008946:0.007533
tection System (Bio-Rad Laboratories) and the final reaction mix consisted of 10 µL Sen-:@0.147059:0.388796:0.882353:0.388796:0.882353:0.368423:0.147059:0.368423:0.006209:0.009108:0.009108:0.006437:0.005547:0.010843:0.011756:0.003550:0.009816:0.009724:0.007510:0.006209:0.009039:0.017645:0.003561:0.006939:0.012486:0.005547:0.011048:0.007533:0.013899:0.009291:0.011391:0.003561:0.011984:0.009108:0.011251:0.010845:0.007896:0.008811:0.006211:0.010843:0.007807:0.005547:0.009039:0.007670:0.006939:0.003550:0.009085:0.011596:0.011391:0.003561:0.006617:0.011302:0.009039:0.003550:0.005684:0.005684:0.011687:0.009405:0.005250:0.003550:0.007442:0.009291:0.009291:0.009108:0.006437:0.005547:0.010843:0.011756:0.003561:0.017645:0.005615:0.010089:0.003561:0.008994:0.010843:0.011619:0.007601:0.005615:0.007510:0.006209:0.009108:0.011391:0.003550:0.010843:0.006209:0.003561:0.010432:0.010432:0.003561:0.010957:0.011619:0.003550:0.010592:0.009039:0.011687:0.007533
siFAST  SYBR ® Lo-Rox mix (Bioline), 0.5 µM forward and reverse primers, 10 ng of :@0.147059:0.409375:0.886482:0.409375:0.886482:0.389002:0.147059:0.389002:0.007601:0.005615:0.009473:0.015066:0.009861:0.013354:0.019539:0.005547:0.009724:0.013354:0.012463:0.013376:0.005547:0.005090:0.005547:0.011824:0.011048:0.007533:0.013694:0.010820:0.010089:0.005547:0.017645:0.005615:0.010089:0.005547:0.006939:0.012486:0.005547:0.010932:0.005250:0.005615:0.011598:0.009039:0.006939:0.004497:0.005547:0.010432:0.004497:0.010432:0.005547:0.010957:0.019608:0.005547:0.006026:0.010843:0.008400:0.014723:0.009085:0.007442:0.011391:0.005547:0.009085:0.011596:0.011391:0.005547:0.007442:0.009336:0.009633:0.009039:0.007624:0.007873:0.009039:0.005547:0.011071:0.007807:0.005615:0.017485:0.009039:0.007624:0.007670:0.004497:0.005547:0.010432:0.010432:0.005547:0.011459:0.009861:0.005547:0.010843:0.006209:0.004109
TM:@0.208485:0.401759:0.227568:0.401759:0.227568:0.389882:0.208485:0.389882:0.007652:0.011432
WGA DNA and Ultrapure DNas/RNAse free H O to bring up the reaction volume to :@0.147059:0.429954:0.886430:0.429954:0.886430:0.409581:0.147059:0.409581:0.020270:0.015682:0.014929:0.005684:0.015773:0.015408:0.014929:0.005684:0.009085:0.011596:0.011391:0.005684:0.015773:0.004908:0.006437:0.007898:0.008811:0.011048:0.011413:0.007442:0.009039:0.005684:0.015773:0.015545:0.009291:0.007670:0.007099:0.013376:0.015408:0.014586:0.007873:0.009039:0.005684:0.006414:0.007442:0.009108:0.009039:0.005684:0.016846:0.006109:0.016412:0.005684:0.006209:0.011048:0.005684:0.010820:0.007807:0.005615:0.011459:0.009861:0.005684:0.011071:0.011276:0.005684:0.006620:0.011299:0.009039:0.005684:0.007442:0.009291:0.009291:0.009106:0.006437:0.005547:0.010843:0.011756:0.005684:0.009635:0.010934:0.004908:0.011413:0.017485:0.009039:0.005684:0.006209:0.011048:0.004109
2:@0.557532:0.433106:0.563614:0.433106:0.563614:0.421229:0.557532:0.421229:0.006082
20 µL. The Cycle conditions were as follows: 14 cycles of 10s at 95°C and 30s at from 65-:@0.147059:0.450532:0.882378:0.450532:0.882378:0.430160:0.147059:0.430160:0.010432:0.010432:0.004177:0.010957:0.011619:0.004497:0.004177:0.011470:0.011311:0.009039:0.004177:0.014541:0.009519:0.008765:0.005182:0.009039:0.004177:0.008994:0.010843:0.011598:0.011391:0.005271:0.006437:0.005547:0.010843:0.011619:0.007670:0.004177:0.014518:0.009039:0.007442:0.009039:0.004177:0.009291:0.007670:0.004177:0.006026:0.010934:0.005387:0.005182:0.010866:0.014723:0.007670:0.004497:0.004177:0.010432:0.010432:0.004177:0.009382:0.009519:0.008765:0.005182:0.009039:0.007670:0.004177:0.010843:0.006209:0.004177:0.010432:0.010432:0.007670:0.004177:0.008811:0.006437:0.004177:0.010432:0.010432:0.007442:0.014678:0.004177:0.009085:0.011596:0.011391:0.004177:0.010432:0.010432:0.007670:0.004177:0.008811:0.006437:0.004177:0.006414:0.007442:0.010843:0.017645:0.004177:0.010432:0.010432:0.007533
58°C (touchdown), followed by 20-40 cycles of 10s at 95°C and 30s at 60°C. In addition, :@0.147059:0.471111:0.886555:0.471111:0.886555:0.450738:0.147059:0.450738:0.010432:0.010432:0.007442:0.014678:0.004132:0.006939:0.006209:0.010820:0.011345:0.008765:0.011299:0.011322:0.010866:0.014723:0.011756:0.006939:0.004497:0.004132:0.006026:0.010934:0.005387:0.005182:0.010866:0.014518:0.009108:0.011391:0.004132:0.010843:0.009724:0.004132:0.010432:0.010432:0.007533:0.010432:0.010432:0.004132:0.009382:0.009519:0.008765:0.005182:0.009039:0.007670:0.004132:0.010843:0.006209:0.004132:0.010432:0.010432:0.007670:0.004132:0.008811:0.006437:0.004132:0.010432:0.010432:0.007442:0.014678:0.004132:0.009085:0.011596:0.011391:0.004132:0.010432:0.010432:0.007670:0.004132:0.008811:0.006437:0.004132:0.010432:0.010432:0.007442:0.014678:0.004497:0.004132:0.006894:0.011756:0.004132:0.009291:0.011322:0.011391:0.005273:0.006437:0.005547:0.010843:0.011756:0.004497:0.004109
a melt curve was generated from 56°C to 95°C to assess the generated PCR products. :@0.147059:0.491690:0.886532:0.491690:0.886532:0.471317:0.147059:0.471317:0.009291:0.006049:0.017485:0.008948:0.004908:0.006437:0.006049:0.009108:0.011413:0.008400:0.009633:0.009039:0.006049:0.014723:0.009291:0.007670:0.006049:0.009656:0.009039:0.011596:0.009039:0.007898:0.008811:0.006209:0.009108:0.011391:0.006049:0.006414:0.007442:0.010843:0.017645:0.006049:0.010432:0.010432:0.007442:0.014678:0.006049:0.006209:0.011048:0.006049:0.010432:0.010432:0.007442:0.014678:0.006049:0.006209:0.011048:0.006049:0.009291:0.007533:0.007875:0.009039:0.007533:0.007670:0.006049:0.006620:0.011299:0.009039:0.006049:0.009656:0.009039:0.011596:0.009039:0.007898:0.008811:0.006209:0.009108:0.011391:0.006049:0.012167:0.014678:0.013376:0.006049:0.011071:0.007442:0.011276:0.011048:0.011345:0.009108:0.006437:0.007670:0.004497:0.004109
Based on qPCR results, two primer sets for the detection of SVs in each patient were :@0.147059:0.512269:0.886528:0.512269:0.886528:0.491896:0.147059:0.491896:0.012874:0.009291:0.007875:0.009108:0.011391:0.006243:0.010843:0.011756:0.006243:0.011025:0.012167:0.014678:0.013376:0.006255:0.007442:0.009039:0.007510:0.011550:0.004908:0.006437:0.007670:0.004497:0.006243:0.006437:0.014518:0.011048:0.006243:0.011071:0.007807:0.005615:0.017485:0.009039:0.007807:0.006255:0.007875:0.009128:0.006437:0.007670:0.006255:0.006026:0.010843:0.007807:0.006243:0.006620:0.011299:0.009039:0.006255:0.011322:0.009131:0.006209:0.009108:0.009106:0.006437:0.005547:0.010843:0.011756:0.006255:0.010843:0.006209:0.006243:0.010112:0.015089:0.007670:0.006255:0.005615:0.011756:0.006243:0.009291:0.009291:0.008765:0.011459:0.006243:0.011368:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.006255:0.014518:0.009039:0.007442:0.009039:0.004109
selected for quantification by digital PCR (dPCR). Primer sets were excluded from use :@0.147059:0.532847:0.886389:0.532847:0.886389:0.512474:0.147059:0.512474:0.007875:0.008948:0.005182:0.009108:0.009108:0.006209:0.009106:0.011391:0.005296:0.006026:0.010843:0.007807:0.005296:0.010706:0.011596:0.009085:0.011391:0.006437:0.005615:0.005684:0.005615:0.009108:0.008811:0.006437:0.005547:0.010843:0.011756:0.005296:0.010843:0.009724:0.005296:0.011391:0.005615:0.009861:0.005271:0.006551:0.009405:0.005250:0.005296:0.012167:0.014678:0.013376:0.005296:0.006939:0.011391:0.012167:0.014678:0.013376:0.006939:0.004497:0.005296:0.011916:0.007807:0.005615:0.017485:0.009039:0.007807:0.005296:0.007875:0.009128:0.006437:0.007670:0.005296:0.014518:0.009039:0.007442:0.009039:0.005296:0.009108:0.009884:0.008765:0.004908:0.011345:0.011322:0.009108:0.011391:0.005296:0.006414:0.007442:0.010843:0.017645:0.005296:0.011413:0.007875:0.009039:0.004109
with dPCR when one of the following ocurred: >1 PCR product, Cq:@0.147059:0.553426:0.739411:0.553426:0.739411:0.533053:0.147059:0.533053:0.014723:0.005273:0.006620:0.011459:0.006152:0.011391:0.012167:0.014678:0.013376:0.006163:0.014792:0.011299:0.009039:0.011756:0.006163:0.010843:0.011596:0.009039:0.006152:0.010843:0.006209:0.006163:0.006620:0.011299:0.009039:0.006163:0.006026:0.010934:0.005387:0.005182:0.010866:0.014723:0.005615:0.011459:0.009861:0.006152:0.011276:0.009108:0.011413:0.007807:0.007442:0.009108:0.011391:0.004497:0.006152:0.011550:0.010432:0.006163:0.012167:0.014678:0.013376:0.006163:0.011071:0.007442:0.011276:0.011048:0.011345:0.009106:0.006437:0.004497:0.006163:0.014997:0.011025
germline:@0.739346:0.556578:0.783515:0.556578:0.783515:0.544701:0.739346:0.544701:0.005629:0.005270:0.004551:0.010354:0.003061:0.003274:0.006760:0.005270
- Cq:@0.783515:0.553426:0.823231:0.553426:0.823231:0.533053:0.783515:0.533053:0.007533:0.006163:0.014995:0.011025
tumor:@0.822903:0.556578:0.854217:0.556578:0.854217:0.544701:0.822903:0.544701:0.003593:0.006654:0.010194:0.006321:0.004551
 <5 :@0.854217:0.553426:0.886471:0.553426:0.886471:0.533053:0.854217:0.533053:0.006163:0.011550:0.010432:0.004109
and/or Cq:@0.147059:0.574005:0.235010:0.574005:0.235010:0.553632:0.147059:0.553632:0.009085:0.011596:0.011391:0.007099:0.010843:0.007807:0.004109:0.014997:0.011025
tumor :@0.234690:0.577157:0.268399:0.577157:0.268399:0.565280:0.234690:0.565280:0.003593:0.006654:0.010194:0.006321:0.004551:0.002395
> 20. :@0.268399:0.574005:0.313528:0.574005:0.313528:0.553632:0.268399:0.553632:0.011550:0.004109:0.010432:0.010432:0.004497:0.004109
DNA sonication and fragment size analysis: To mimic the length of cfDNA and improve :@0.147059:0.615162:0.886465:0.615162:0.886465:0.594789:0.147059:0.594789:0.015773:0.015408:0.014929:0.003844:0.007875:0.010843:0.011756:0.005547:0.009108:0.008811:0.006437:0.005547:0.010843:0.011756:0.003846:0.009085:0.011596:0.011391:0.003846:0.006412:0.007898:0.009199:0.009861:0.017485:0.009039:0.011391:0.006437:0.003846:0.007601:0.005615:0.008834:0.009039:0.003846:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670:0.004495:0.003846:0.010866:0.011048:0.003844:0.017645:0.005615:0.017645:0.005547:0.008994:0.003846:0.006617:0.011302:0.009039:0.003844:0.005182:0.009039:0.011459:0.009861:0.006620:0.011459:0.003846:0.010843:0.006209:0.003844:0.008994:0.006209:0.015773:0.015408:0.014929:0.003846:0.009085:0.011596:0.011391:0.003846:0.005615:0.017280:0.011071:0.007442:0.010868:0.009633:0.009039:0.004109
DNA molecule partition, WGA DNA of both tumor and germline were sonicated to a :@0.147059:0.635741:0.886482:0.635741:0.886482:0.615368:0.147059:0.615368:0.015773:0.015408:0.014929:0.005341:0.017485:0.010934:0.005182:0.009108:0.009108:0.011550:0.005182:0.009039:0.005341:0.011368:0.009085:0.007967:0.006437:0.005273:0.006437:0.005547:0.010843:0.011756:0.004497:0.005341:0.020270:0.015682:0.014929:0.005341:0.015773:0.015408:0.014929:0.005341:0.010840:0.006209:0.005341:0.011251:0.010820:0.006620:0.011459:0.005341:0.006163:0.011413:0.017485:0.010843:0.007807:0.005341:0.009085:0.011596:0.011391:0.005341:0.009656:0.009039:0.007807:0.017759:0.005250:0.005615:0.011596:0.009039:0.005341:0.014518:0.009039:0.007442:0.009039:0.005341:0.007873:0.010845:0.011756:0.005545:0.009108:0.008811:0.006209:0.009108:0.011391:0.005341:0.006211:0.011048:0.005341:0.009291:0.004109
peak size of ~150 bp with the S220 Focused-ultrasonicator (Covaris) according to the :@0.147059:0.656319:0.886462:0.656319:0.886462:0.635947:0.147059:0.635947:0.011505:0.009291:0.009405:0.010523:0.005809:0.007601:0.005615:0.008834:0.009039:0.005809:0.010843:0.006209:0.005809:0.011779:0.010432:0.010432:0.010432:0.005809:0.010797:0.011276:0.005809:0.014723:0.005273:0.006620:0.011459:0.005809:0.006620:0.011299:0.009039:0.005809:0.010112:0.010432:0.010432:0.010432:0.005809:0.010683:0.011276:0.009108:0.011413:0.007875:0.009106:0.011391:0.007533:0.011550:0.004908:0.006437:0.007898:0.009291:0.007875:0.010843:0.011756:0.005547:0.009108:0.008811:0.006209:0.010843:0.007807:0.005809:0.006939:0.014997:0.010866:0.009838:0.009085:0.007807:0.005615:0.007670:0.006939:0.005809:0.009291:0.008994:0.008994:0.010843:0.007442:0.011391:0.005615:0.011459:0.009861:0.005809:0.006209:0.011048:0.005809:0.006620:0.011299:0.009039:0.004109
manufacturer’s protocol. The sonication conditions were as follows; 200-250 ng WGA :@0.147059:0.676898:0.886510:0.676898:0.886510:0.656525:0.147059:0.656525:0.017577:0.009085:0.011391:0.011413:0.006209:0.009291:0.009108:0.006163:0.011413:0.007442:0.009039:0.007076:0.001735:0.007670:0.005935:0.011071:0.007442:0.010820:0.006209:0.011276:0.008994:0.010934:0.004976:0.004497:0.005935:0.011470:0.011311:0.009039:0.005935:0.007875:0.010843:0.011756:0.005547:0.009108:0.008811:0.006437:0.005547:0.010843:0.011756:0.005935:0.008994:0.010843:0.011596:0.011391:0.005273:0.006437:0.005547:0.010843:0.011619:0.007670:0.005935:0.014518:0.009039:0.007442:0.009039:0.005935:0.009291:0.007670:0.005935:0.006026:0.010934:0.005387:0.005182:0.010866:0.014723:0.007670:0.004497:0.005935:0.010432:0.010432:0.010432:0.007533:0.010432:0.010432:0.010432:0.005935:0.011459:0.009861:0.005935:0.020270:0.015682:0.014929:0.004109
DNA (concentration determined by Qubit  fluorometric quantitation) in 50 µL Ultra-:@0.147059:0.697477:0.882353:0.697477:0.882353:0.677104:0.147059:0.677104:0.015773:0.015408:0.014929:0.004406:0.006939:0.008994:0.010843:0.011596:0.008994:0.009039:0.011391:0.006437:0.007898:0.008811:0.006437:0.005547:0.010843:0.011756:0.004406:0.011322:0.009131:0.006209:0.009039:0.007807:0.017645:0.005615:0.011596:0.009108:0.011391:0.004406:0.010843:0.009724:0.004406:0.016433:0.011345:0.010822:0.005271:0.006437:0.019066:0.004406:0.005638:0.005296:0.011345:0.010843:0.007442:0.010843:0.017485:0.009131:0.006437:0.007807:0.005547:0.008994:0.004406:0.010706:0.011596:0.009085:0.011391:0.006437:0.005273:0.006551:0.008811:0.006437:0.005547:0.010843:0.011756:0.006939:0.004406:0.005615:0.011756:0.004406:0.010432:0.010432:0.004406:0.010957:0.011619:0.004406:0.015773:0.004908:0.006437:0.007898:0.009262:0.007533
TM:@0.506036:0.689861:0.525119:0.689861:0.525119:0.677983:0.506036:0.677983:0.007652:0.011432
pure DNas/RNAse free H O, Peak Incident Power: 175 W, Duty Factor: 10 %, Cycles per :@0.147059:0.718056:0.886508:0.718056:0.886508:0.697683:0.147059:0.697683:0.011048:0.011413:0.007442:0.009039:0.004086:0.015773:0.015545:0.009291:0.007670:0.007099:0.013376:0.015408:0.014586:0.007875:0.009039:0.004086:0.006414:0.007442:0.009108:0.009039:0.004086:0.016846:0.006068:0.015385:0.004497:0.004086:0.011162:0.009291:0.009405:0.010523:0.004086:0.006896:0.011596:0.008994:0.005547:0.011322:0.009039:0.011391:0.006437:0.004086:0.011162:0.010866:0.014518:0.009039:0.008126:0.004497:0.004086:0.010432:0.010432:0.010432:0.004086:0.017394:0.004497:0.004086:0.016230:0.011071:0.006437:0.009724:0.004086:0.010729:0.009291:0.009108:0.006209:0.010843:0.008126:0.004497:0.004086:0.010432:0.010432:0.004086:0.015043:0.004497:0.004086:0.014541:0.009519:0.008765:0.005182:0.009039:0.007670:0.004086:0.011505:0.009039:0.007807:0.004109
2:@0.362759:0.721208:0.368840:0.721208:0.368840:0.709331:0.362759:0.709331:0.006082
Burst: 200, Treatment Time: 280 s, Temperature: 7°C, and Water Level: 12. After soni-:@0.147059:0.738634:0.882353:0.738634:0.882353:0.718261:0.147059:0.718261:0.012509:0.011413:0.007624:0.007510:0.006437:0.004497:0.005684:0.010432:0.010432:0.010432:0.004497:0.005684:0.011231:0.007442:0.009291:0.008811:0.006437:0.017485:0.009039:0.011391:0.006437:0.005684:0.012737:0.005615:0.017485:0.009039:0.004497:0.005684:0.010432:0.010432:0.010432:0.005684:0.007670:0.004497:0.005684:0.010866:0.009039:0.017280:0.011505:0.009039:0.007896:0.008813:0.006163:0.011413:0.007442:0.009039:0.004497:0.005684:0.010432:0.007442:0.014678:0.004497:0.005684:0.009087:0.011596:0.011391:0.005684:0.018786:0.008811:0.006209:0.009039:0.007807:0.005684:0.011824:0.009336:0.009633:0.008948:0.005250:0.004497:0.005684:0.010432:0.010432:0.004497:0.005684:0.014929:0.006197:0.005969:0.009039:0.007807:0.005684:0.007875:0.010843:0.011756:0.005656:0.007533
cation DNA fragment sizes were analyzed with the High Sensitivity DNA kit (Agilent :@0.147059:0.759213:0.886464:0.759213:0.886464:0.738840:0.147059:0.738840:0.009108:0.008811:0.006437:0.005547:0.010843:0.011756:0.006003:0.015773:0.015408:0.014929:0.006003:0.006414:0.007898:0.009199:0.009861:0.017485:0.009039:0.011391:0.006437:0.006003:0.007601:0.005615:0.008834:0.009039:0.007670:0.006003:0.014518:0.009039:0.007442:0.009039:0.006003:0.009085:0.011687:0.009405:0.005182:0.009724:0.008834:0.009108:0.011391:0.006003:0.014723:0.005273:0.006620:0.011459:0.006003:0.006620:0.011299:0.009039:0.006003:0.016481:0.005615:0.009930:0.011459:0.006003:0.010592:0.009039:0.011619:0.007601:0.005273:0.006437:0.005547:0.009838:0.005273:0.006437:0.009724:0.006003:0.015773:0.015408:0.014929:0.006003:0.010706:0.005273:0.006437:0.006003:0.006939:0.014678:0.009861:0.005752:0.005182:0.009039:0.011391:0.006437:0.004109
Technologies) on the Bioanalyzer (Agilent Technologies) and the sample concentration :@0.147059:0.779792:0.886418:0.779792:0.886418:0.759419:0.147059:0.759419:0.010866:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.009861:0.005547:0.009039:0.007670:0.006939:0.004794:0.010843:0.011756:0.004794:0.006620:0.011299:0.009039:0.004794:0.012486:0.005547:0.011139:0.009085:0.011687:0.009405:0.005182:0.009724:0.008834:0.009039:0.007807:0.004794:0.006939:0.014678:0.009861:0.005752:0.005182:0.009039:0.011391:0.006437:0.004794:0.010866:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.009861:0.005547:0.009039:0.007670:0.006939:0.004794:0.009085:0.011596:0.011391:0.004794:0.006620:0.011299:0.009039:0.004794:0.007941:0.009087:0.017280:0.011162:0.005182:0.009039:0.004794:0.008994:0.010843:0.011596:0.008994:0.009039:0.011391:0.006437:0.007898:0.008811:0.006437:0.005547:0.010843:0.011756:0.004109
was re-quantified by Qubit  fluorometric quantitation (Invitrogen, Life Technologies, :@0.147059:0.800370:0.886491:0.800370:0.886491:0.779998:0.147059:0.779998:0.014723:0.009291:0.007670:0.005456:0.007442:0.009039:0.007533:0.010706:0.011596:0.009085:0.011391:0.006437:0.005615:0.005684:0.005615:0.009108:0.011391:0.005456:0.010843:0.009724:0.005456:0.016435:0.011345:0.010820:0.005273:0.006437:0.019065:0.005456:0.005638:0.005296:0.011345:0.010845:0.007442:0.010843:0.017485:0.009131:0.006437:0.007807:0.005547:0.008994:0.005456:0.010706:0.011596:0.009085:0.011391:0.006437:0.005273:0.006551:0.008811:0.006437:0.005547:0.010843:0.011756:0.005456:0.006939:0.006894:0.011368:0.009838:0.005273:0.006437:0.007442:0.011048:0.009656:0.009039:0.011756:0.004497:0.005456:0.011731:0.005615:0.006026:0.009039:0.005456:0.010866:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.009861:0.005547:0.009039:0.007670:0.004497:0.004109
TM:@0.376609:0.792754:0.395693:0.792754:0.395693:0.780877:0.376609:0.780877:0.007652:0.011432
Carlsbad, CA, USA). :@0.147059:0.820949:0.326591:0.820949:0.326591:0.800576:0.147059:0.800576:0.014974:0.009085:0.007601:0.005250:0.007670:0.011117:0.009291:0.011117:0.004497:0.004109:0.014678:0.014929:0.004497:0.004109:0.016024:0.010112:0.014929:0.006939:0.004497:0.004109
Design of digital PCR assays for absolute quantification of SVs in cfDNA: To quantify :@0.147059:0.862107:0.886461:0.862107:0.886461:0.841734:0.147059:0.841734:0.016230:0.009039:0.007601:0.005615:0.009861:0.011756:0.005693:0.010843:0.006209:0.005695:0.011391:0.005615:0.009861:0.005273:0.006551:0.009402:0.005250:0.005695:0.012167:0.014678:0.013376:0.005693:0.009291:0.007533:0.007944:0.008925:0.009724:0.007670:0.005695:0.006026:0.010843:0.007807:0.005695:0.009108:0.010934:0.007875:0.010932:0.004910:0.011069:0.006211:0.009039:0.005693:0.010706:0.011596:0.009085:0.011391:0.006437:0.005615:0.005684:0.005615:0.009108:0.008811:0.006437:0.005547:0.010843:0.011756:0.005693:0.010845:0.006209:0.005693:0.010112:0.015089:0.007670:0.005695:0.005615:0.011756:0.005693:0.008994:0.006209:0.015773:0.015408:0.014929:0.004499:0.005695:0.010866:0.011048:0.005693:0.010706:0.011596:0.009085:0.011391:0.006437:0.005615:0.006506:0.009724:0.004109
SVs in cfDNA, dPCR was performed. First, the exact position of the breakpoint as de-:@0.147059:0.882685:0.882353:0.882685:0.882353:0.862312:0.147059:0.862312:0.010112:0.015089:0.007670:0.005341:0.005615:0.011756:0.005341:0.008994:0.006209:0.015773:0.015408:0.014929:0.004497:0.005341:0.011391:0.012167:0.014678:0.013376:0.005341:0.014723:0.009291:0.007670:0.005341:0.011505:0.009039:0.007807:0.006026:0.010843:0.007807:0.017485:0.009108:0.011117:0.004497:0.005341:0.011391:0.005615:0.007624:0.007510:0.006437:0.004497:0.005341:0.006620:0.011299:0.009039:0.005341:0.009108:0.010089:0.009291:0.009108:0.006437:0.005341:0.011505:0.010957:0.007601:0.005273:0.006437:0.005547:0.010843:0.011756:0.005341:0.010843:0.006209:0.005341:0.006620:0.011299:0.009039:0.005341:0.010820:0.007442:0.009291:0.009402:0.010272:0.011505:0.010843:0.005615:0.011391:0.006437:0.005341:0.009291:0.007670:0.005341:0.011322:0.009108:0.007533
termined by nanopore sequencing was validated. We used already available sequenced :@0.147059:0.903264:0.886530:0.903264:0.886530:0.882891:0.147059:0.882891:0.006209:0.009039:0.007807:0.017645:0.005615:0.011596:0.009108:0.011391:0.005410:0.010843:0.009724:0.005410:0.011687:0.009085:0.011596:0.010820:0.011505:0.010843:0.007442:0.009039:0.005410:0.007875:0.009108:0.010703:0.011347:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.005410:0.014723:0.009291:0.007670:0.005410:0.009838:0.009405:0.005250:0.005545:0.011573:0.008811:0.006209:0.009108:0.011117:0.004497:0.005410:0.018649:0.009039:0.005410:0.011413:0.007875:0.009108:0.011391:0.005410:0.009405:0.005250:0.007442:0.009291:0.009291:0.011322:0.009724:0.005410:0.008925:0.009838:0.009085:0.005752:0.005433:0.009106:0.010911:0.005184:0.009039:0.005410:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.009108:0.011391:0.004109